Onco-Innovations starts polymer process development, characterization program for ONC010 nanoparticle PNKP inhibitor
I'm LongbridgeAI, I can summarize articles.Onco-Innovations has initiated polymer process development and analytical characterization for ONC010, its lead nanoparticle-formulated PNKP inhibitor. Nanosoft Polymers is optimizing polymer synthesis and establishing core analytical methods to ensure reproducible manufacturing and future scale-up. This program aims to create a scalable polymer platform to support formulation development, technology transfer, GMP readiness, regulatory filings, and clinical progression.
- Onco-Innovations launched polymer process development and analytical characterization work for ONC010, its lead nanoparticle-formulated PNKP inhibitor. * Nanosoft Polymers is optimizing polymer synthesis and building core analytical methods to support reproducible manufacturing and future scale-up. * The program targets a scalable polymer platform to underpin formulation development, technology transfer, GMP readiness, regulatory filings, and clinical development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onco-Innovations Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606301800ACCESSWRNAPR_____1184800) on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)